UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunohistochemical markers to diagnose primary squamous cell carcinoma of the lung: a meta-analysis of diagnostic test accuracy

Therapeutic Advances in Medical Oncology, 2022-02, Vol.14, p.17588359211065152-17588359211065152

2022

Volltextzugriff (PDF)

Comparison between next‐generation sequencing and multiplex polymerase chain reaction assays for nonsmall‐cell lung cancer molecular diagnosis

Cancer medicine (Malden, MA), 2024-04, Vol.13 (7), p.e7162-n/a

2024

Volltextzugriff (PDF)

Reproducibility of the T-SPOT.TB test for screening Mycobacterium tuberculosis infection in Japan

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020-02, Vol.26 (2), p.194-198

2020

Volltextzugriff (PDF)

Clinically-meaningful improvements in therapy for unresectable NSCLC

Expert review of anticancer therapy, 2022-09, Vol.22 (9), p.927-937

2022

Volltextzugriff (PDF)

Resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in non‐small cell lung cancer patients: A meta‐analysis

Thoracic cancer, 2021-04, Vol.12 (7), p.1096-1105

2021

Volltextzugriff (PDF)

MicroRNA‐200b is a potential biomarker of the expression of PD‐L1 in patients with lung cancer

Thoracic cancer, 2020-10, Vol.11 (10), p.2975-2982

2020

Volltextzugriff (PDF)

T‐cell response to phytohemagglutinin in the interferon‐γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non‐small cell lung cancer

Thoracic cancer, 2021-06, Vol.12 (11), p.1726-1734

2021

Volltextzugriff (PDF)

Class A CpG oligodeoxynucleotide inhibits IFN‐γ‐induced signaling and apoptosis in lung cancer

Thoracic cancer, 2020-04, Vol.11 (4), p.983-992

2020

Volltextzugriff (PDF)

Non‐small cell lung cancer with mesenchymal–epithelial transition gene exon 14 skipping mutation treated with crizotinib

Respirology case reports, 2019-10, Vol.7 (7), p.e00453-n/a

2019

Volltextzugriff (PDF)

The Efficacy and Safety of Dexmedetomidine and Propofol Versus Midazolam Alone in Adult Patients Undergoing Endobronchial Ultrasound-guided Transbronchial Needle Aspiration: a Retrospective Analysis

The Journal of the Japan Society for Respiratory Endoscopy, 2019/11/25, Vol.41(6), pp.563-568

2019

Volltextzugriff (PDF)

Afatinib + bevacizumab combination therapy in EGFR‐mutant NSCLC patients with osimertinib resistance: Protocol of an open‐label, phase II, multicenter, single‐arm trial

Thoracic cancer, 2020-08, Vol.11 (8), p.2125-2129

2020

Volltextzugriff (PDF)

Combination treatment options for small-cell lung cancer

The lancet oncology, 2021-03, Vol.22 (3), p.e83-e83

2021

Volltextzugriff (PDF)

P77-10 Efficacy of amrubicin after immuno-chemotherapy for extensive-stage small-cell lung cancer

Annals of oncology, 2022-07, Vol.33, p.S544

2022

Volltextzugriff (PDF)

MO29-1 The relationship between EGFR variant allele frequency and efficacy of osimertinib in EGFR mutation-positive NSCLC

Annals of oncology, 2022-07, Vol.33, p.S500

2022

Volltextzugriff (PDF)

Machine learning prediction of prognosis in lung cancer with inter-institutional generalizability: A multicenter cohort study (WJOG15121L: REAL-WIND)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.8571-8571

2024

Volltextzugriff (PDF)

First-line immune checkpoint inhibitors alone or in combination with chemotherapy in real-life elderly patients with advanced non-small cell lung cancer (NEJ057)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.9012-9012

2023

Volltextzugriff (PDF)

Identification of a novel biomarker based on lymphocyte count, albumin level, and TBAg/PHA ratio for differentiation between active and latent tuberculosis infection in Japan

Tuberculosis (Edinburgh, Scotland), 2020-12, Vol.125, p.101992-101992, Article 101992

2020

Volltextzugriff (PDF)

Identification of Biomarkers for Non–small-cell Lung Cancer Patients Treated With an Immune Checkpoint Inhibitor

Anticancer research, 2020-07, Vol.40 (7), p.3889-3896

2020

Volltextzugriff (PDF)

Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell Lung Cancer

JAMA oncology, 2024-04, Vol.10 (4), p.439

2024

Volltextzugriff (PDF)

The best regimens for chemo-naïve incurable non-squamous non- small cell lung cancer with a programmed death-ligand 1, tumor proportion score 1–49%: a network meta-analysis

Translational lung cancer research, 2021-08, Vol.10 (8), p.3550-3566

2021

Volltextzugriff (PDF)

Best regimens for treating chemo‐naïve incurable squamous non‐small cell lung cancer with a programmed death‐ligand 1 tumor proportion score of 1%–49%: A network meta‐analysis

Thoracic cancer, 2022-01, Vol.13 (1), p.84-94

2022

Volltextzugriff (PDF)

EP8-4. Identification of biomarker to distinguish active and latent tuberculosis infection

Annals of The Japanese Respiratory Society, 2020-08, Vol.9 (suppl), p.339-339

2020

Volltextzugriff (PDF)

EPD1-7. Reliability of T-SPOT, TB for Screening of Mycobacterium Tuberculosis Infection in Japan

Annals of The Japanese Respiratory Society, 2018-03, Vol.7 (suppl), p.346-346

2018

Volltextzugriff (PDF)

超音波気管支鏡ガイド下生検（EBUS-TBNA）におけるプロポフォール・デクスメデトミジン併用鎮静の有用性と安全性の検討

気管支学, 2019/11/25, Vol.41(6), pp.563-568

2019

Volltextzugriff (PDF)

Non-small cell lung cancer with mesenchymal-epithelial transition gene exon 14 skipping mutation treated with crizotinib

Respirology case reports, 2019, Vol.7 (7), p.e00453-e00453

2019

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(24)
Berichte
(1)

Sprache

Englisch
(21)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(14)
Science & Technology
(14)
Lung Cancer
(11)
Oncology
(11)
Chemotherapy
(7)
Humans
(7)
Original
(7)
Respiratory System
(7)
Cancer Therapies
(6)
Lung Neoplasms - Drug Therapy
(6)
Mutation
(6)
Patients
(6)
Biomarkers
(5)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(4)
Immunotherapy
(4)
Kinases
(4)
Cytotoxicity
(3)
Epidermal Growth Factor
(3)
Immune Checkpoint Inhibitors
(3)
Ligands
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Immunohistochemical markers to diagnose primary squamous cell carcinoma of the lung: a meta-analysis of diagnostic test accuracy

Comparison between next‐generation sequencing and multiplex polymerase chain reaction assays for nonsmall‐cell lung cancer molecular diagnosis

Reproducibility of the T-SPOT.TB test for screening Mycobacterium tuberculosis infection in Japan

Clinically-meaningful improvements in therapy for unresectable NSCLC

Resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in non‐small cell lung cancer patients: A meta‐analysis

MicroRNA‐200b is a potential biomarker of the expression of PD‐L1 in patients with lung cancer

T‐cell response to phytohemagglutinin in the interferon‐γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non‐small cell lung cancer

Class A CpG oligodeoxynucleotide inhibits IFN‐γ‐induced signaling and apoptosis in lung cancer

Non‐small cell lung cancer with mesenchymal–epithelial transition gene exon 14 skipping mutation treated with crizotinib

The Efficacy and Safety of Dexmedetomidine and Propofol Versus Midazolam Alone in Adult Patients Undergoing Endobronchial Ultrasound-guided Transbronchial Needle Aspiration: a Retrospective Analysis

Afatinib + bevacizumab combination therapy in EGFR‐mutant NSCLC patients with osimertinib resistance: Protocol of an open‐label, phase II, multicenter, single‐arm trial

Combination treatment options for small-cell lung cancer

P77-10 Efficacy of amrubicin after immuno-chemotherapy for extensive-stage small-cell lung cancer

MO29-1 The relationship between EGFR variant allele frequency and efficacy of osimertinib in EGFR mutation-positive NSCLC

Machine learning prediction of prognosis in lung cancer with inter-institutional generalizability: A multicenter cohort study (WJOG15121L: REAL-WIND)

First-line immune checkpoint inhibitors alone or in combination with chemotherapy in real-life elderly patients with advanced non-small cell lung cancer (NEJ057)

Identification of a novel biomarker based on lymphocyte count, albumin level, and TBAg/PHA ratio for differentiation between active and latent tuberculosis infection in Japan

Identification of Biomarkers for Non–small-cell Lung Cancer Patients Treated With an Immune Checkpoint Inhibitor

Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell Lung Cancer

The best regimens for chemo-naïve incurable non-squamous non- small cell lung cancer with a programmed death-ligand 1, tumor proportion score 1–49%: a network meta-analysis

Best regimens for treating chemo‐naïve incurable squamous non‐small cell lung cancer with a programmed death‐ligand 1 tumor proportion score of 1%–49%: A network meta‐analysis

EP8-4. Identification of biomarker to distinguish active and latent tuberculosis infection

EPD1-7. Reliability of T-SPOT, TB for Screening of Mycobacterium Tuberculosis Infection in Japan

超音波気管支鏡ガイド下生検（EBUS-TBNA）におけるプロポフォール・デクスメデトミジン併用鎮静の有用性と安全性の検討

Non-small cell lung cancer with mesenchymal-epithelial transition gene exon 14 skipping mutation treated with crizotinib

Suchergebnisse filtern